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Recent studies have shown that wild-type and recombinant adeno-associated virus (AAV and rAAV) genomes
persist in human tissue predominantly as double-stranded (ds) circular episomes derived from input linear
single-stranded virion DNA. Using self-complementary recombinant AAV (scAAV) vectors, we generated
intermediates that directly transition to ds circular episomes. The scAAV genome ends are palindromic
hairpin-structured terminal repeats, resembling a double-stranded break repair intermediate. Utilizing this
substrate, we found cellular DNA recombination and repair factors to be essential for generating circular
episomal products. To identify the specific cellular proteins involved, the scAAV circularization-dependent
vector was used as a reporter in 19 mammalian DNA repair-deficient cell lines. The results show that RecQ
helicase family members (BLM and WRN), Mre11 and NBS1 of the Mre11-Rad50-Nbs1 (MRN) complex, and
ATM are required for efficient scAAV genome circularization. We further demonstrated that the scAAV genome
requires ATM and DNA-PKCS, but not NBS1, to efficiently convert to a circular form in nondividing cells in
vivo using transgenic mice. These studies identify specific pathways involved for further elucidating viral and
cellular mechanisms of DNA maintenance important to the viral life cycle and vector utilizations.
Adeno-associated virus (AAV) and AAV-derived vectors
(recombinant AAV [rAAV]) deliver a single-stranded DNA
genome, which must be converted into double-stranded DNA
(dsDNA) by the host cell. This process is normally carried out
by utilizing the hairpinned inverted terminal repeats (TRs) in
a self-priming replication mechanism (3). After this conver-
sion, the vector genome undergoes additional changes medi-
ated by host cell recombination factors acting on the AAV TR
ends (30). Most of the vector DNA circularizes, but when the
dose is high enough to deliver multiple genomes to the nu-
cleus, they can join end to end to form concatemers, which also
can circularize (11–13). A small number of vector genomes are
integrated into the host chromosome, putatively through sim-
ilar recombination reactions between the TRs and chromo-
somal double-strand breaks (DSBs) (30, 32, 34, 45). Though
relatively little is known about the cellular factors that partic-
ipate in these reactions, these recombinations ultimately gov-
ern the stability of rAAV DNA and the potential for adverse
interactions with genomic DNA sequences. Persistence of the
vector genome in the host cell is a critical parameter for suc-
cessful use of rAAV for gene delivery. In preclinical and clin-
ical trials, rAAV genomes have been documented to persist in
monkeys and humans for over 6 and 3.7 years, respectively
(41). More recently, the molecular fate of both wild-type (wt)
AAV in humans and rAAV in animals has been demonstrated
to be persistence as episomal circles (5, 47, 48). This observa-
tion strongly suggests that wt and vector AAV genomes are
utilizing similar host recombination pathways. While the cor-
relation between long-term persistence of rAAV genomes and
conversion to circular and concatemeric forms has been noted
in numerous studies, it is not clear that the linear rAAV ge-
nome is inherently subject to loss of gene expression through
nucleolytic degradation or by other mechanisms. Rather, the
linear form of the genome represents a transient episomal
phase in normal cells due to the recombinogenic activity of the
free DNA ends. It is therefore important to understand how
mammalian DNA repair and recombination systems partici-
pate in conversion of linear rAAV genomes to more stable
structures.
The repair of DSBs generally involves the recognition of
broken DNA ends by signaling molecules followed by repair by
several proteins, each performing a specific biochemical reac-
tion. DNA breaks with little or no homology can be repaired by
the “cut-and-paste” mechanism of nonhomologous end joining
(NHEJ), which is carried out by Ku70/80 heterodimers, DNA-
dependent protein kinase (DNA-PKCS), ligase IV, XRCC4,
Artemis, Warner protein (WRN), and others. When homolo-
gous sequence is available (e.g., sister chromatids), DNA
breaks can be repaired with higher accuracy by homologous
recombination (HR), carried out by the Mre11/Rad50/NBS1
(MRN) complex, XRCC2 and XRCC3, Rad51 and its paral-
ogs, DNA polymerases and ligases, and others.
Several previous studies have demonstrated that DSB repair
proteins associate with the rAAV genome and affect its fate in
different ways. First, the catalytic subunit of DNA-PKCS affects
the efficiency of rAAV genome circularization. In mice lacking
DNA-PKCS (SCID mice), rAAV vector DNA recovered from
muscle contains a significant fraction of linear molecules,
which are not seen in normal mice (14, 50). In contrast, rAAV
DNA extracted from liver tissue in SCID mice is circularized,
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though the chromosomal integration frequency of vector DNA
is higher in these animals than in the livers of normal mice
(51). The involvement of DNA-PKCS implicates the NHEJ
repair pathway when AAV TRs are utilized and further sug-
gests that vector DNA template circularization and integration
may be competing recombination end products. When AAV
vectors were previously characterized for nontargeted integra-
tion in dividing cells in vitro, NHEJ appeared to be the likely
pathway (32, 43). Host proteins are not only involved in AAV
vector persistence and wt AAV integration but also associated
with other steps of viral replication. DNA DSB repair proteins
Ku80 (involved in NHEJ) and Rad52 (involved in HR) are
recruited to AAV nuclear replication compartments during
productive infection (24, 40) and have been shown to interact
with the rAAV genome, enhancing or regulating transduction
(39, 68). These observations, and AAV dependency on host
factors and helper virus for successful replication, reflect the
virus classification as Dependovirus.
The circularization of rAAV genomes in normal cells can be
inhibited by coinfection with adenovirus (Ad), and this activity
has been mapped to the Ad E4 region (11, 13). Two of the Ad
E4 gene products, ORF3 and ORF6, augment Ad growth by
preventing the end-to-end joining of the replicating genomes
(60). The E4 ORF6 and the Ad E1b55K proteins form a
complex that promotes the degradation of two important DNA
repair-associated proteins, Mre11 and p53. The Ad E4 ORF3
protein can act alone to sequester Mre11, again inhibiting the
end-to-end joining of Ad genomes. These results would sug-
gest that either Mre11 or p53, or both, participates in recom-
bination between AAV TRs, leading to circularization of the
genome.
In order to systemically test the involvement of specific DNA
DSB repair pathway proteins in the mechanism of AAV TR
recombination, we utilized a previously developed reporter
system using self-complementary AAV (scAAV) vectors (7).
These vectors were designed to express green fluorescent pro-
tein (GFP) only after specific recombination events such as
intramolecular recombination to form circles (Fig. 1A) or spe-
cific intermolecular interactions to form concatemers (7). Us-
ing this system, we previously demonstrated that recombina-
tion between closed hairpin ends was favored over that
between open ends and that closed hairpin end recombination
was more sensitive to inhibition of specific cellular factors
including topoisomerase I and DNA polymerase //ε (7).
In this study we identify cellular proteins required for
scAAV TR recombination, in order to better understand
which DNA repair pathways are important for this process. We
utilize our previously described reporter gene rescue system to
provide a sensitive genetic readout of recombination efficiency
in specific DNA repair-deficient cell lines and in mutant mice.
Our results support the premise that the AAV TR is recog-
nized as a DNA DSB in mammalian cells, and many host DSB
repair proteins, such as ATM, Mre11, NBS1, BLM, WRN, and
DNA-PKCS, contribute to AAV TR recombination. In addi-
tion, using these substrates, we demonstrate for the first time
correlation of AAV circle formation and transgene expression
in vivo in nondividing tissue and extend this analysis to mutant
mice deficient in critical host DNA repair proteins.
MATERIALS AND METHODS
Cell lines and maintenance of cells. Cell lines used in this study were obtained
from the ATCC (Manassas, VA) and the Coriell Institute (Camden, NJ) and
were generously provided by other investigators (19, 23, 37, 38, 53–57). All cell
lines used in this study (Table 1) were cultured at 37°C in a 5% CO2 humidified
incubator in medium and with modifications as described in Table 2. Expression
of ATR-wt (GW33 cells) and ATR-kinase dead (kd) (GK41 cells) can be induced
by treating cells with 1 g/ml doxycycline for 48 h prior to viral infection. Drug
treatment was continued during the course of viral infection. All cell lines used
in this study can be categorized according to their cell types and origins, which
are kidney fibroblast, cervical carcinoma, foreskin fibroblast, lung fibroblast, skin
fibroblast, glioblastoma, osteosarcoma, colon cancer, and Chinese hamster ovary
(CHO) cells (Table 1).
Viral vector construction and vector purification. The construction of viral
vectors GFP1 and GFP2 and the circularization-dependent vector
scAAVGFP-cd was described previously (7) (Fig. 1A). Viruses were generated
using the triple transfection method with AAV serotype 2 capsid (16, 63) and
purified by discontinuous iodixanol gradient separation and heparin chromatog-
raphy (52). The viral vectors were characterized by dot blot hybridization and
infectious center assays in C12 cells (8, 69).
FIG. 1. (A) Reporter system to study scAAV genome circulariza-
tion. The schematic depicts the gene structures in the positive-control
vectors, GFP2 and GFP1, and the circularization-dependent experi-
mental vector, scAAVGFP-cd, shown in linear (left) and circular
(right) conformations. CMV, cytomegalovirus. (B) Normalization of
infectious dose in different recombination-deficient cell lines. A rep-
resentative dose-response study was performed to determine the op-
timal viral dose to be used for an scAAV circularization experiment on
different cell types of recombination-deficient cell lines (Table 2). Cell
lines Irs1(ex), V79-4, and Irs3 are derived from CHO cells. All of the
cell lines used in this study were normalized in this way.
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Infection and quantification by flow cytometry. Circularization assays were
performed by infecting cells in 6-well or 12-well plates at a low multiplicity of
infection with equal infectious units of scAAVGFP-cd or the vectors containing
the intact GFP cassette in either orientation (GFP1 and GFP2). The dosage was
adjusted for equivalent transduction in different cell lines by prior titration with
the GFP2 vector. Medium with virus was replaced with fresh medium 3 to 4 h
postinfection.
Cells were harvested 24 h postinfection, washed with ice-cold phosphate-
buffered saline, and fixed with 1% formaldehyde in phosphate-buffered saline on
ice. The GFP expression in transduced cells was analyzed by fluorescence-
activated cell sorting using a FACScan1 (Becton-Dickinson) cytometer. Forward
and side scatter setting parameters were set according to the size of the cell types,
and the setting for fluorochrome detection was adjusted so that the fluorescence
intensity of uninfected negative-control cells fell within the first decade of the
4-decade log scale.
Animal procedures. Three mouse lines were used in this study. ATM trans-
genic mice (background strains 129 and C57BL/6J) were a generous gift from
Terry Van Dyke (University of North Carolina at Chapel Hill) (2, 15, 65).
NBSB transgenic mice (background strains C57BL/6 and 129Sv) were a gen-
erous gift from John Petrini (Memorial Sloan-Kettering Cancer Center) (61).
SCID mice (background strain C57BL/6J) were obtained from Jackson Labora-
tory and housed in a clean cubicle due to their immunodeficiency (4). ATM and
NBSB mice were bred in-house by crossing heterozygous males and females
because both sexes of ATM homozygous mice and female homozygous mice of
NBSB are nonfertile. The genotypes of the animals were determined by PCR
using primers specific to the gene of interest with exon knockouts as described in
previous studies (Table 3) (2, 61). Wild-type littermates were used as positive
controls.
Mice were injected with vector under anesthesia at 6 to 10 weeks of age. An
incision was made medial to the injection site to avoid scar formation above the
area expressing GFP. After the muscle was exposed, equal infectious units (10 l
total volumes) of GFP1 and scAAVGFP-cd vector were injected manually into
the right and left gastrocnemius, respectively, of each animal by using a 30-gauge
needle over the course of 2 min to minimize vector leakage and dissemination.
Animal imaging procedure for GFP detection and data analysis. A Macro-
molecular Illumination System (Lightools) was used to monitor the kinetics of
GFP expression in the muscles of the mice over time. At each time point, mice
were anesthetized with Avertin (15 l to 17 l/g body weight) and the fur on top
of the gastrocnemius was chemically depilated. Images acquired were analyzed
by Image J software. Briefly, the total amount of GFP light emission was calcu-
lated as the area of visible signal multiplied by the average measured fluores-
cence intensity. The efficiency of vector circularization was determined as a ratio
of GFP expression calculated by dividing the expression level of scAAVGFP-cd
vector (left leg) with the expression level of GFP1 (right leg) for each image.
Individual images were taken for each mouse at each time point. The ratios
calculated for mice with the same genotype were averaged and presented as
means together with standard errors.
RESULTS
To determine which DSB repair proteins participate in AAV
TR recombination, we utilized the previously described circu-
larization-dependent self-complementary adeno-associated vi-
ral vector (scAAVGFP-cd) as a reporter system for studying
recombination events (Fig. 1A) (7). Human skin fibroblast and
CHO cell lines deficient in specific genes required for DSB
repair previously established and characterized by other inves-
tigators were obtained for this study (19, 23, 37, 38, 53–57).
Since AAV is known to transduce cell lines of different origins
with varying efficiency (6), we normalized the amount of virus
added to each cell type for infection efficiency such that all cell
lines were evaluated at the same multiplicity of infection. Us-
ing AAV serotype 2 capsid, we performed titration experi-
ments on each cell line with control vectors GFP1 and GFP2 as
previously described (7). These vector DNA templates have
contiguous cytomegalovirus-GFP expression cassettes in two
orientations with respect to the closed-end TR and will express
GFP regardless of the circularization status of the genome
(Fig. 1A). Therefore, the number of GFP-expressing cells rep-
resents the number of functional genomes delivered to the
nucleus. A dose-response experiment using the positive-con-
trol vectors (GFP1 and GFP2) was performed on each cell line
(Table 1; data not shown), and a representative titration ex-
periment is presented in Fig. 1B. As predicted from the liter-
ature, even cell lines of similar origin [CHO Irs1(ex), V79-4,
and Irs3] have different susceptibilities to AAV2 infection (Fig.
1B). Equivalent dose-response curves were established for all
cell lines (data not shown) to ensure that a similar percentage
TABLE 1. Summary of cell lines used in the current studya
Species, cell type,






C12 AAV2 rep and cap integrated
SF
NHF-hTERT Positive control
AT-hTERT ATM/termination (103C3T) HR/NHEJ







GM16088 Ligase IV NHEJ










HCT116 p53/ p53 positive control MMR










CXR3 XRCC3  hXRCC3
PXR3 XRCC3  hXRCC3
V79-4 Positive control
Irs1(ex) XRCC2 HR
Irs1X2.1 XRCC2  hXRCC2
Irs1X2.2 XRCC2  hXRCC2
Irs3 Rad51c HR
a Abbreviations: BER, base excision repair; CC, cervical carcinoma; CoC,
colon cancer; GB, glioblastoma; MMR, mismatch repair; NER, nucleotide ex-
cision repair; OS, osteosarcoma; RecQH, RecQ helicase; SF, skin fibroblast;
TC-NER, transcription-coupled nucleotide excision repair; TS, tumor suppres-
sor; kd, kinase dead.
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of cells was infected when scAAVGFP-cd reagents were
tested. In addition, in order to measure only expression due to
circularization of monomeric genomes and not from concate-
merized genomes, we used a multiplicity of infection that
achieves only 10 to 15% infection of cells. Previously under
these conditions we established that it is highly unlikely for
there to be more than one genome per infected cell nucleus
(7). Because all of the vectors used in this study were scAAV,
which folds into a double-stranded DNA conformation without
the requirement for cellular DNA synthesis, the majority of
vector DNA released into the nucleus should be immediately
available as functional substrates for recombination. The ob-
served differences in transduction efficiencies with control vec-
tor in different cell lines reflected expected variations at mul-
tiple steps including attachment to the cell, internalization, and
trafficking to the nucleus. There were no observed differences
in transduction between the two control vectors in any one cell
line. Because the control and experimental vectors differ only
in the arrangement of primary sequence, and not DNA con-
formation, they are expected to be identically manipulated
according to the available recombination factors specific to
that cell line. In all cell line-based experiments, the number of
GFP-expressing cells infected with scAAVGFP-cd was com-
pared to that of cells infected with control vector GFP1 or
GFP2 in order to calculate the percent circularization.
Requirement for specific DSB repair proteins in scAAV ge-
nome circularization. Double-strand break repair is a multistep,
multipathway mechanism involving a large number of proteins
performing specific sequential enzymatic reactions. The two main
DSB repair pathways are HR and NHEJ (Fig. 2A) (22, 25, 59),
both of which are active to various degrees in dividing cell cul-
tures.
Figure 2B shows percent vector DNA circularization in each
recombination-deficient cell line compared to the analogous
wild-type cell line (NHF-hTERT for human fibroblasts and
CHO-K1, A8, and V79-4 for CHO cells) and/or the parent
recombination-deficient cell line complemented with the miss-
ing factor (XRCC2  XRCC2 and XRCC3  XRCC3, cell
lines that are stably transfected with cDNA of the correspond-
ing wild-type missing protein). We also tested cells that were
TABLE 2. Summary of medium formulations used in the current study
Formulation Cell line(s) Componentsa
1 AG05012, AG02496, AG03962, AG06040, GM07166,
GM00037
Eagle’s MEM with Earle’s salts (Gibco 11095), 1 Pen-Strep,
15% uninactivated FBS (Sigma), and 1 nonessential amino
acids (Gibco 11140)
2 AG000780H, GM16096, GM16088 Eagle’s MEM with Earle’s salts (Gibco 11095), 1 Pen-Strep,
10% uninactivated FBS (Sigma), and 1 nonessential amino
acids (Gibco 11140)
3 M059K, M059J DMEM–F-12 (ATCC 30-2006), 1 Pen-Strep, and 10%
uninactivated FBS (Sigma)
4 GM16147 Ham’s F-12 (Gibco 11765), 1 Pen-Strep, 5% uninactivated
FBS (Sigma), and 1 mM L-glutamine (Gibco 25030)
5 CHO-K1 Ham’s F-12 (Gibco 11765), 1 Pen-Strep, 10% uninactivated
FBS (Sigma), and 1 mM L-glutamine (Gibco 25030)
6 Xrs5, AA8, V3-3, Irs1SF, Irs1SFwt5, Irs1SFwt6, EM-9 -MEM (Gibco 12561), 1 Pen-Strep, and 10% uninactivated
FBS (Sigma)
7 HeLa, SAOS2 DMEM (Sigma D6429), 1 Pen-Strep, and 10% uninactivated
FBS (Sigma)
8 GW33, GK41 -MEM (Gibco 12561), 1 Pen-Strep, 10% uninactivated
FBS (Sigma), 200 g/ml G418 (Gibco 10131), and 200 g/ml
hygromycin B (Roche 843 555)
9 C12 DMEM (Sigma D6429), 1 Pen-Strep, 500 g/ml G418
(Gibco 10131), and 10% uninactivated FBS (Sigma)
10 U2OS, HCT116 p53/, HCT116 p53/ McCoy’s 5A modified, 1 Pen-Strep, and 10% uninactivated
FBS (Sigma)
a Abbreviations: MEM, minimal essential medium; Pen, penicillin; Strep, streptomycin; FBS, fetal bovine serum; DMEM, Dulbecco modified Eagle medium.
TABLE 3. PCR primers and conditions for genotyping transgenic animals
Strain Primer names and sequences (melting temps) Step no. and cycling conditions
ATM IMR0013, 5 CTT GGG TGG AGA GGC TAT TC (59°C); IMR0014,
5 AGG TGA GAT GAC AGG AGA TC (54°C); IMR0640, 5
GCT GCC ATA CTT GAT CCA TG (59°C); IMR0641, 5 TCC
GAA TTT GCA GGA GTT G (60°C)
1, 94°C for 3 min; 2, 94°C for 20 s; 3, 64°C
for 30 s (0.5°C/cycle); 4, 72°C for 35 s
(repeat steps 2 to 4 12 times); 5, 94°C
for 20 s; 6, 58°C for 30 s; 7, 72°C for
35 s (repeat steps 5 to 7 25 times); 8,
72°C for 2 min; 9, 4°C
NBSB mp95.a7, TCC AGT TGT TTG CGG TAA GTC CTC (64.6°C);
mp95.s3, GAT AGA GTT ACC TTT GGG GTG TTT (61.2°C);
p95.N, TTT GCC AAG TTC TAA TTC CAT CAG (59.4°C)
1, 94°C for 3 min; 2, 94°C for 1 min; 3,
60°C for 1 min; 4, 72°C for 1 min
(repeat steps 2 to 4 34 times); 5, 72°C
for 5 min; 6, 4°C
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FIG. 2. scAAV circularization experiment using recombination-deficient human and Chinese hamster ovary cells. (A) DNA double-stranded
break repair pathways. The major known components of HR and NHEJ are depicted. (B) Each cell line was infected with 5 to 50 IU/cell of
scAAVGFP-cd vector and the two control vectors, GFP1 and GFP2 (the values of which were averaged), in triplicate or quadruplicate in multiple
experiments. The percent vector circularization was calculated from the percentage of GFP-positive cells infected with scAAVGFP-cd vector
divided by the average of the percentages of GFP-positive cells infected with the two control vectors. Asterisk, percent vector circulation in mutant
cells compared to that in the analygous wild-type cells, as described in Table 1 and in the text.
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wild type for DSB repair (human fibroblast XPC, CSA, and
CHO cell XRCC1 lines) but with deficiencies in nuclear exci-
sion repair or base excision repair. An average of 87% and
96% of the scAAV genomes circularized in wt human fibro-
blast and CHO control cell lines, respectively (Fig. 2). Repair-
deficient cell lines were considered negative if the efficiency of
circularization was lower than 2 standard deviations below the
average of the control cell lines (Fig. 2).
Broken DNA ends are recognized by signaling molecules,
which then initiate the DNA repair processes. We selected a
few signaling molecules previously shown to be involved in
DSB, including ataxia-telangiectasia mutated (ATM); ataxia
telangiectasia, Rad3-related protein (ATR); and p53 to test for
their requirement in scAAV TR recombination. The ATM-
mutant 1 cell line carries an unknown mutation in ATM, and
the ATM-mutant 2 cell line carries a C3T point mutation at
nucleotide 103. The efficiency of circularization in these cells
was 23% and 16% of wt levels, respectively, suggesting that
ATM plays an important role (Fig. 2B, left panel, in yellow). In
contrast, cells overexpressing ATR-wt and ATR-kinase dead
(ATR-kd) proteins showed no significant differences in circu-
larization, suggesting that ATR is not essential for this type of
recombination (Fig. 2B, left panel, in blue).
p53 protein is another central signaling molecule believed to
play a role in DNA repair that also functions as a transcription
factor controlling cell cycle and apoptosis. In SAOS2 cells
(p53/) and U2OS cells (p53/), we observed no difference
in circularization efficiency (data not shown). Since these two
cell lines had different genetic backgrounds, we also tested
isogenic cell lines, HCT116 p53/ and HCT116 p53/,
which also suggested that p53 is not required (data not shown).
Since p53 is an ATM substrate (phosphorylation at Ser15), this
suggested that scAAV TR recombination utilizes an ATM-
dependent, p53-independent pathway. Interestingly, since
HCT116 cells are mismatch repair deficient, these data also
suggested that mismatch repair is not part of the scAAV TR
recombination pathway.
Next, we tested the roles of NBS1 and Mre11, which are part
of the MRN complex and are believed to be involved in both
HR and NHEJ recombination pathways. As shown in Fig. 2B
(right panel, in yellow), the efficiency of scAAV genome cir-
cularization was 53% and 64%, respectively. We also tested
two RecQ helicase family members, Bloom (BLM) and
Warner (WRN), to assess the contribution of their DNA-
unwinding functions. The efficiency of circularization in BLM
and WRN cells was 62% and 64%, respectively (Fig. 2A, right
panel, in yellow). These results indicated that the absence of
NBS1, Mre11, BLM, or WRN partially inhibits circularization,
which suggests that the MRN complex and the two RecQ
helicases contribute to TR recombination.
The next group of molecules tested performs various DNA
coordinating functions at sites of recombination and repair in
the HR pathway (XRCC2, XRCC3, and Rad51c) or in NHEJ
(Ku80, DNA-PKCS, and XRCC4). Cells deficient in XRCC2
and XRCC3, as well as Ku80 and XRCC4, were competent in
scAAV genome circularization at levels similar to those of the
wt cells, while the Rad51c-deficient cell line was marginally less
effective (Fig. 2B, right panel, in blue). This suggests that none
of these proteins are absolutely required for AAV TR recom-
bination. DNA-PKCS protein, previously identified as an im-
portant factor in rAAV circularization and integration in vivo,
was also tested using our reporter system in DNA-PKCS-defi-
cient CHO and human glioblastoma cell lines. Interestingly,
the absence of DNA-PKCS in human MO59J cells resulted in
a slightly higher percentage of circularization than in the anal-
ogous DNA-PKCS-expressing cell line (MO59K) (Fig. 2B, right
panel, *DNA-PKCS-human). Similarly, in DNA-PKCS-defi-
cient CHO cells (V3-3), circularization was not significantly
reduced (Fig. 2B, right panel, DNA-PKCS-CHO). These re-
sults using the circularization-dependent GFP vector assay in
vitro were inconsistent with our study (see below) and other in
vivo studies using DNA-PKCS-deficient mice (50, 51), suggest-
ing that there is an alternate pathway for AAV genome circu-
larization available in the DNA-PKCS-deficient cultured cells
tested in this study (see Discussion).
Finally, we tested the requirements for two mammalian
DNA ligases, one involved in HR (DNA ligase I) and the other
in NHEJ (DNA ligase IV). In both deficient cell lines, the
efficiency of genome circularization was comparable to that of
the control cells, suggesting that additional ligases are available
to complete the recombination process (Fig. 2B, right panel, in
blue). In conclusion, of the 19 DNA repair-deficient cell lines
tested (Table 1), ATM, Mre11, NBS1, BLM, and WRN pro-
teins contributed to efficient scAAV genome circularization
(Fig. 2A, highlighted in yellow).
Requirement for DNA repair proteins in scAAV circulariza-
tion in transgenic animals. The in vitro study using recombi-
nation-deficient cell lines allowed us to screen a large number
of candidate cellular molecules for their involvement in TR
recombination. However, the tissue of interest for gene ther-
apy usually contains nondividing or slowly dividing cells (e.g.,
muscle and liver). In addition, the role of these proteins in
specific cell types may be either more pronounced or silenced
depending on conditions (e.g., B-cell differentiation versus
neuron). We therefore tested rAAV genome circularization in
vivo, testing specifically in a cell type commonly used for rAAV
delivery, namely, muscle, and observed GFP expression over
time using a live imaging system. Because adipose can substan-
tially block the excitation and emission light for GFP reporter
in animal studies, the gastrocnemius muscle was chosen as a
target due to its size and lack of adipose tissue. To normalize
for animal-to-animal variation, the mice were injected with a
control scAAV vector (GFP1) in the right leg and the circu-
larization-dependent vector (scAAVGFP-cd) in the left leg
(Fig. 3A). A representative image is shown in Fig. 3A (ATM
wild-type littermate and transgenic knockout). The percent
circularization was determined for each animal by comparing
the scAAVGFP-cd vector signal to the control vector GFP1
signal and quantified using Image J software (NIH) [percent
circulation 	 (GFP-cd signal/GFP-control signal)  100%].
The quantification of percent circularization is graphed in Fig.
3B, C, and D. The y axis represents the average value of
percent circularization. DNA repair-deficient animals (red
dashed line) were plotted against wild-type littermates (blue
solid line) (Fig. 3B and C) or background-matched controls
(see Materials and Methods; Fig. 3D) over time. The results
from the in vivo experiments are also summarized in Table 4.
ATM. Because our cultured cell assays pointed to ATM as
the most significant effector of TR recombination, we tested
the requirement for this factor in ATM-deficient animals. In wt
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littermates, circularization was 70% complete by day 14,
climbed to 90% by 42 days, and plateaued thereafter (Fig. 3B,
blue solid line). In the ATM-deficient animals, which were
bred from heterozygous siblings, we observed three pheno-
types of homozygous pups. One type died within 4 weeks of
birth, prior to injection. The second type survived for 42 days
postinjection, and the remaining third type survived up to 70
days postinjection. In the injected ATM-deficient animals, only
10% of scAAVGFP-cd vector had circularized at 14 days
postinfection. This percentage remained flat till day 42 and
then increased to 40% by day 70 (Fig. 3B, red dashed line). We
note, however, that this increase may be due to the predispo-
sition for lymphoma caused by ATM mutation (six out of nine
transgenic mice died by 42 days postinjection as described
above, leaving only three mice at the last time point). This
would have influenced the analysis because the animals that
had the highest circularization signals from the outset ulti-
mately lived the longest, probably reflecting the observed vari-
ation in expressivity of the mutant phenotype. Regardless, we
concluded that ATM was required for efficient circularization
of scAAV genomes in the muscle, consistent with our obser-
vations in ATM-deficient cell lines.
NBS1. In the NBS1-deficient cell lines, circularization was
approximately half of that observed in normal cells. As NBS1
deletion is embryonic-lethal, Petrini and coworkers (61) were
able to develop an NBSB mouse model, in which only a
subset of protein functions were inactivated by truncation of
the gene. This mutant protein, although not equivalent, still
resembles some of the phenotypes of the NBS1 deficiency seen
in human patients. The scAAV circularization efficiency in
NBSB mice was approximately half that of the wild-type
littermates at 2 weeks postinjection but was not significantly
different at later time points (Fig. 3C). The P value of the t test
(P 	 0.0776) confirms that the result is statistically insignifi-
cant. This suggested that either NBS1 is not required for TR
recombination or this specific NBSB mutation that carries
partial function to escape embryonic lethality is sufficient in
this setting. We also noted that the NBSB wt littermates
reached only 70% circularization at the end of the study.
FIG. 3. Kinetic study of the requirement for cellular proteins in
scAAV genome circularization in vivo. (A) Illustration of direct muscle
injection in transgenic and wild-type littermates and representative
fluorescence images of GFP expression from the scAAV control vec-
tor, GFP1, and cir-dept vector in mouse gastrocnemius using the mac-
romolecular imaging system. The image was taken 28 days postinjec-
tion. (B) ATM. Equal numbers of vector infectious units were injected
into the gastrocnemius of the wt and deficient animals (left leg,
scAAVGFP-cd vector; right leg, control GFP1 vector). Animals were
imaged at the indicated time points. n 	 12 samples for wt group and
n 	 9 samples for ATM-knockout group (P value is 0.0016). (C)
NBSB. The same experimental protocol as in panel B above was
used. The NBSB mouse model carries a different mutation than the
NBS1 mutation carried in the human skin fibroblasts (see Discussion
and the references). n was three samples for the wt group and five
samples for the NBSB group (P value is 0.0776). (D) DNA-PKCS.
The same experimental protocol as in panel B above was used. n was
eight samples for the wt group and eight samples for the SCID group
(P value is 0.0001). Animals were imaged at indicated time points.
Statistical analysis (two-independent-sample t test) was performed,
and error bars represent standard deviations of the means.
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This was different from ATM wt littermates, which reached
90% circularization (compare Fig. 3B to 3C, blue lines),
demonstrating the influence of the genetic background and
underscoring the importance of using the matched back-
ground controls.
DNA-PKCS. In our in vitro experiments, the high circular-
ization efficiency in MO59J (DNA-PKCS deficient) compared
to MO59K (isogenic cells with wt DNA-PKCS) cells conflicted
with several previous studies of AAV TR recombination in
SCID mice. When we tested scAAV circularization in SCID
mice, GFP expression from scAAVGFP-cd reached only 50%
of that from the control vector, GFP1, by 14 days postinjection,
and this difference was maintained through 12 weeks postin-
jection (Fig. 3D). This was in general agreement with previous
studies using rAAV vector in SCID muscle and liver tissue and
highlighted the different requirements for specific DNA repair
factors in cultured cells versus animal tissues, a theme that has
been documented before with other aspects of rAAV efficiency
of transgene delivery (6). Nonetheless, these animal studies
demonstrate the importance of the scAAV circularization-de-
pendent reagent as a molecular substrate for studying DNA
repair both in vitro and in vivo.
DISCUSSION
The ability of the AAV genome to persist as episomes relies
exclusively on cellular proteins to convert the linear genome
into stable circular and concatemeric structures. It is inferred
that these resultant DNA intermediates contribute to long-
term gene expression in vivo, now over 6 years in nonhuman
primates (41) and 3.7 years in humans (H. Jiang, G. F. Pierce,
et al., 8th Ann. Meet. Am. Soc. Gene Therapy, abstr., 1 to 5
June 2005). With this knowledge in hand, the recombination
mechanism responsible for circularization and concatemeriza-
tion of AAV genomes is still poorly understood. To identify
cellular proteins involved in this process, we utilized a novel
scAAV GFP reporter system to assay recombination between
AAV TRs in DNA repair-deficient cells and transgenic mice.
Six different cellular factors were found to contribute signifi-
cantly to genome circularization: ATM, Mre11, NBS1, WRN,
BLM, and DNA-PKCS. ATM was required both in cultured
cells and in transgenic animals, while NBS1 was required only
in cultured cells and DNA-PKCS only in animals. No single
mutation completely eliminated vector genome circularization,
suggesting a great deal of redundancy in the ability of various
host proteins to act on and use AAV TR structures as recom-
bination substrates. This redundancy is consistent with the
paramount importance of repairing DSBs in order to maintain
the integrity of the host genome (57). With respect to wild-type
AAV, recent studies have identified only the circular form of
the viral genome persisting in human tissue (5, 48). This infor-
mation is complemented by numerous studies showing long-
term persistence of AAV vectors as circles and concatemers in
vivo (5, 12, 47, 48, 62). The only element in common between
wt AAV and rAAV vectors is the cis-acting 145-bp terminal
repeat. Since AAV vectors do not carry any viral coding se-
quences, the formation of circular DNA structures for both wt
and vector is likely to be dependent on host mechanisms.
There are multiple pathways for DNA damage repair in the
mammalian cell, principally orchestrated by three proteins of
the phosphatidylinositol 3-kinase kinase family of Ser/Thr pro-
tein kinases: ATM, ATR, and DNA-PKCS. Our observed in-
hibition of circularization in ATM mutants, and not in ATR
mutants, supports the premise that the cell recognizes scAAV
TRs as double-strand breaks. While both of these factors are
important signaling molecules for DNA damage, ATM is pri-
marily involved in repair of DSBs caused by ionizing radiation,
while ATR responds to damage by UV irradiation or chemi-
cally induced lesions (49).
In a previous study, in which UV-irradiated rAAV was used
to study the relationship between the AAV genome and cel-
lular DNA repair proteins, ATR protein was implicated (24).
Infection of p53-deficient cells with the UV-irradiated rAAV
resulted in cell death, and the viral genome was processed by
ATR but not the ATM/NBS1 pathway (24, 40). This observa-
tion under these specific conditions is consistent with the role
of ATR in the repair of UV-induced DNA damage. In another
study, ATM-deficient cells displayed a considerably higher
transduction efficiency as well as circular and head-to-tail con-
catemeric DNA structures when infected with a conventional
single-stranded rAAV vector (46). In trying to reconcile these
TABLE 4. Summary of in vivo experimental results from ATM, NBSB, and SCID mice
Time point and strain
of animals
% Circularization (n)
compared to intact vector Conclusion
wt KOa
14 days Circularization in all transgenic animals was less efficient than that in their
wt littermates at the early stage of viral infection
ATM 70 (12) 10 (9)
NBSB 45 (3) 20 (5)
SCID 55 (8) 20 (8)
Last day Circularization in ATM transgenic and SCID animals was about half as
efficient as that in their wt littermates. NBSB transgenic animals could
convert genomes to circles at least as efficiently as their wt littermates
could
ATM (70 days) 90 (12) 40 (4)
NBSB (140 days) 75 (3) 90 (5)
SCID (113 days) 90 (8) 50 (5)
a KO, knockout.
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observations with decreased transduction in our study, we pro-
pose three possible explanations. One, the ATM-deficient cell
lines used in the two studies were different and may contain
secondary mutations that have not yet been characterized.
Two, the availability of recombination-independent internal
control vectors (GFP1 and GFP2, Fig. 1A) allowed us to nor-
malize the amount of virus required to achieve equal numbers
of functional genomes per cell (e.g., Fig. 1B). This option was
not available to Sanlioglu et al. (46), and as a result, we ob-
served higher susceptibility of the two ATM-deficient cell lines
than of the corresponding wt control cells (data not shown).
Finally, we were fortunate to be able to validate our in vitro
observation using transgenic animals deficient only in ATM
(Fig. 3B). For these reasons, we feel that ATM does play a
critical role in AAV recombination. However, even with these
likely explanations we should not lose sight of the fact that
AAV vectors delivering single-stranded substrates as primary
vectors for the DNA genome may be acted upon in the cell
differently than the more recently developed scAAV vectors.
For this reason, further characterization with both substrates is
warranted. Differences between single-stranded and self-com-
plementary rAAVs, if any, will only enlighten the field as to
how these dependoviruses interact with cellular DNA repair
functions.
Several previous studies also implicated DNA-PKCS in pro-
cessing rAAV genomes in mouse muscle and liver. In SCID
mice, lacking DNA-PKCS, circularization of rAAV was inhib-
ited in muscle (14, 50), though not in liver (51). However,
chromosomal integration of vector DNA was increased in liver,
possibly due to a delay in circularization. We also found that
DNA-PKCS was important for rAAV circularization in SCID
mouse muscle but was not required in deficient cell cultures.
DNA-PKCS is a central component of the NHEJ repair mech-
anism, which is the predominant pathway of DSB repair in
mammalian cells through all phases of the cell cycle, though its
greatest impact is in G0/G1, when HR is not available (9, 21,
42). Therefore, our observation that the DNA-PKCS pheno-
type is observable only in the nondividing cells of the mouse
muscle in vivo is consistent with the importance of NHEJ in
these cells. In contrast, repair of DSB by HR could compensate
for lack of NHEJ in our DNA-PKCS-deficient dividing cell
cultures, providing a logical explanation for why we observed
different results with our circularization-dependent assay in
vitro versus in vivo.
Two factors from the MRN complex, Mre11 and NBS1, also
contributed to AAV TR recombination in cell lines. However,
the NBS1 mutation available in transgenic animals did not
affect GFP reporter recombination in muscle cells of these
animals. The differential requirements for NBS1 in muscle
versus cell cultures may again relate to the different repair
pathways operating in nondividing versus dividing cells. It also
draws attention to the fact that the NBS1 mice required the use
of a selective mutant protein in order to escape the embryonic
lethality of the true NBS1-knockout phenotype (61). The
MRN complex is primarily associated with ATM-initiated HR
repair, though it may have an overlapping role in NHEJ initi-
ated by the DNA-PK complex (26). Therefore, we would ex-
pect to see the greatest effect on scAAV circularization in
repair-deficient cell lines and not in the muscle. In addition to
its 3-to-5 exonuclease activity on dsDNA, Mre11 is an endo-
nuclease that nicks non-base-paired regions of both dsDNA
hairpins and stem-loop structures (10). The dependence on
Mre11 for efficient AAV genome circularization in our in vitro
study suggests that mammalian hairpin endonucleases play an
important role in AAV TR recombination, and the MRN
complex may serve this role in the context of HR-mediated
repair. An important role for Mre11 in AAV TR recombina-
tion is also consistent with the previous observation that coin-
fection with Ad inhibits circularization of rAAV genomes (11,
13). While the Ad E4 gene products can sequester or degrade
both Mre11 and p53, our results suggest that only Mre11 is
required for this effect, since p53-deficient cells circularized
the rAAV genome efficiently.
The observation that the ATM protein had a profound effect
on scAAV circularization in muscle cells is intriguing, since it
is primarily associated with HR repair. However, recent find-
ings strongly suggest that ATM has an important signaling role
in the repair of a subset of DSBs through the NHEJ pathway
(26). These putatively complex lesions represent approxi-
mately 10% of DSBs generated by ionizing radiation and are
repaired with a slower kinetic in association with the Artemis
protein. ATM-activated Artemis carries out multiple DNA-
processing activities including hairpin nicking, endonucleolytic
resection of overhanging 5 and 3 ends, and resolution of
DNA flap structures (27). This suggests the possibility that the
processing of one or both types of scAAV ends (open or closed
hairpin structures) requires the Artemis protein, at least in the
context of the NHEJ repair pathway. On the other hand, ATM
has many additional downstream signaling targets in response
to DNA damage (57), and these may contribute directly or
indirectly to efficient AAV TR recombination.
Two additional gene products, WRN and BLM, were found
to effect scAAV circularization in deficient cell lines. Both of
these proteins belong to the RecQ family of helicases, which
preferentially bind to and unwind substrates mimicking DNA
replication and recombination intermediates (20, 58). Both
WRN and BLM exhibit 3-to-5 helicase activity and strand-
annealing activities, promoting the strand exchange step in
homologous recombination (28, 29). The WRN protein also
has 3-to-5 exonuclease activity. WRN colocalizes with both
DSB repair and DNA replication sites and may function in
restarting stalled or collapsed replication forks. A recent re-
port suggests that WRN does not participate in NHEJ but has
an essential role in single-strand annealing (SSA), an alternate
form of HR (28, 66). In SSA, the 5 DNA ends are unwound
or degraded to expose 3 single-strand tails, as in classical HR,
but instead of forming a synapse with a sister chromatid, the
two exposed ends are base paired with one another via small
regions of chance homology. The nonhomologous tails are
then trimmed off, and the two ends are ligated. Repair by SSA
does not require Rad51, which mediates the strand invasion
step of classical HR, but does involve the MRN complex (17,
66). This is consistent with the requirements for Mre11 and
NBS1, but not for Rad51c, XRCC2, and XRCC3, which are all
specific for classical HR, in our circularization assays in defi-
cient cell lines. A role for SSA in AAV TR end joining is
particularly attractive since rAAV-host chromosome DNA
junctions are characterized by just such microhomologies (2 to
6 bp) (30, 44, 67). In the context of rAAV circularization, the
homologies within the internal palindromes of each TR could
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serve to coordinate the two ends, giving rise to a “double D”
terminal repeat structure previously described in AAV recom-
bination intermediates and making up a large component of
rAAV circularization junction products (13, 64).
Like WRN, the BLM protein promotes strand exchange and
branch migration through combined helicase and strand an-
nealing activities (1). It has been specifically associated with
mitotic HR through synthesis-dependent strand annealing in
Drosophila melanogaster, wherein an exposed 3 tail invades the
duplex DNA on the sister chromatid and is extended by DNA
polymerase  (31). While in meiotic cells these structures are
generally resolved by crossover recombination, in mitotic cells
the newly synthesized strand is displaced and base paired to the
3 tail of its associated broken DNA end (35). While it is
unclear if or how synthesis-dependent strand annealing might
contribute to recombination between two AAV TRs, the large-
scale net synthesis of DNA from a recombination partner
could explain the chromosomal duplications that have been
observed in some rAAV integration junctions (33). In a sim-
pler model of scAAV circularization, the contributions of both
these RecQ helicases may derive from the general resem-
blances between the open-end AAV TR and that of a stalled
DNA replication fork, or they may act to resolve recombina-
tion intermediates.
In summary, we present evidence that recombination be-
tween AAV TRs can proceed through multiple pathways, in-
cluding NHEJ in quiescent cells and HR in dividing cells.
There is suggestive evidence that the HR component may rely
on the SSA mechanism. Further, we suggest that similar mech-
anisms of recombination contribute to the random integration
of rAAV vector DNA at sites of chromosomal DSB repair.
Since circular intermediates have been identified in wt AAV
infection (5, 48) and from vector delivery (47) and since the TR
is the only sequence element shared between these viral DNA
substrates, the recombination mechanism occurring at the TR
becomes crucial in understanding AAV genome persistency.
Similar to other viral vectors having an uncontrolled risk of
insertional mutagenesis (18, 36), only a complete characteriza-
tion of the mechanisms and kinetics of these recombination
pathways will allow an assessment of the potential for rAAV
gene therapy genotoxicity. In this study, we described a novel
AAV molecular substrate (scAAVGFP-cd) and assayed for
specific host DNA recombination proteins involved in AAV
persistence both in vitro and in vivo. The data and substrates
described in this study should facilitate our working under-
standing of rAAV persistence and allow further study of
such mechanisms in various target tissues (e.g., brain, heart,
lung, and liver) currently being tested for rAAV human
gene delivery.
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